Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tetrodotoxin for Chemotherapy-Induced Neuropathic Pain
NCT01655823Phase 2Terminated
- Sponsor
- Dogwood Therapeutics, Inc.
- Start
- Jul 2012
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tetrodotoxin in chemotherapy-induced peripheral neuropathy (CIPN), sponsored by Dogwood Therapeutics, Inc.. Started Jul 2012; status: terminated.
02
Drugs
tetrodotoxin
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on NCT01655823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01655823.